Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1999-6-22
pubmed:abstractText
Serous cells are the predominant site of cystic fibrosis transmembrane conductance regulator expression in the airways, and they make a significant contribution to the volume, composition, and consistency of the submucosal gland secretions. We have employed the human airway serous cell line Calu-3 as a model system to investigate the mechanisms of serous cell anion secretion. Forskolin-stimulated Calu-3 cells secrete HCO-3 by a Cl-offdependent, serosal Na+-dependent, serosal bumetanide-insensitive, and serosal 4,4'-dinitrostilben-2,2'-disulfonic acid (DNDS)-sensitive, electrogenic mechanism as judged by transepithelial currents, isotopic fluxes, and the results of ion substitution, pharmacology, and pH studies. Similar studies revealed that stimulation of Calu-3 cells with 1-ethyl-2-benzimidazolinone (1-EBIO), an activator of basolateral membrane Ca2+-activated K+ channels, reduced HCO-3 secretion and caused the secretion of Cl- by a bumetanide-sensitive, electrogenic mechanism. Nystatin permeabilization of Calu-3 monolayers demonstrated 1-EBIO activated a charybdotoxin- and clotrimazole- inhibited basolateral membrane K+ current. Patch-clamp studies confirmed the presence of an intermediate conductance inwardly rectified K+ channel with this pharmacological profile. We propose that hyperpolarization of the basolateral membrane voltage elicits a switch from HCO-3 secretion to Cl- secretion because the uptake of HCO-3 across the basolateral membrane is mediated by a 4,4 '-dinitrostilben-2,2'-disulfonic acid (DNDS)-sensitive Na+:HCO-3 cotransporter. Since the stoichiometry reported for Na+:HCO-3 cotransport is 1:2 or 1:3, hyperpolarization of the basolateral membrane potential by 1-EBIO would inhibit HCO-3 entry and favor the secretion of Cl-. Therefore, differential regulation of the basolateral membrane K+ conductance by secretory agonists could provide a means of stimulating HCO-3 and Cl- secretion. In this context, cystic fibrosis transmembrane conductance regulator could serve as both a HCO-3 and a Cl- channel, mediating the apical membrane exit of either anion depending on basolateral membrane anion entry mechanisms and the driving forces that prevail. If these results with Calu-3 cells accurately reflect the transport properties of native submucosal gland serous cells, then HCO-3 secretion in the human airways warrants greater attention.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-1313448, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-1694404, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-1700622, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-1713921, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-1744699, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-1770448, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-2158772, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-2413776, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-2417229, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-2458473, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-2548387, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-2657051, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-2687566, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-2915212, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-6314153, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-6833997, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7509347, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7512555, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7515498, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7515578, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7515579, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7533841, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7539125, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7540133, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7543240, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7680322, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7692897, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7694492, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-7865639, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-8612275, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-8866361, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-8944721, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9142943, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9142951, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9163427, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9235899, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9277350, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9326665, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9379168, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9380751, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9396783, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9435576, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9530182, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9651366, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9730970, http://linkedlifedata.com/resource/pubmed/commentcorrection/10228185-9922378
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1-ethyl-2-benzimidazolinone, http://linkedlifedata.com/resource/pubmed/chemical/4,4'-dinitro-2,2'-stilbenedisulfonic..., http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Bicarbonates, http://linkedlifedata.com/resource/pubmed/chemical/Bumetanide, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Chlorides, http://linkedlifedata.com/resource/pubmed/chemical/Diuretics, http://linkedlifedata.com/resource/pubmed/chemical/Forskolin, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, http://linkedlifedata.com/resource/pubmed/chemical/Stilbenes
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-1295
pubmed:author
pubmed:issnType
Print
pubmed:volume
113
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
743-60
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
More...